Article examines molecular markers of neuropsychological functioning among elders with and without Alzheimer's disease (AD) and determine the predictive ability of combined molecular markers and select neuropsychological tests in detecting disease presence. This work provides the foundation for the generation of a point‐of‐care device that can be used to screen for AD
PublishedJournal ArticleMulticenter StudyResearch Support, Non-U.S. Gov'tBACKGROUND: The study aimed...
Previous mass spectrometry analysis of cerebrospinal fluid (CSF) has allowed the identification of a...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
Article examines molecular markers of neuropsychological functioning among elders with and without A...
AbstractBackgroundThe current project sought to examine molecular markers of neuropsychological func...
Prior work on the link between blood-based biomarkers and cognitive status has largely been based on...
The ability to detect the presence of many neurodegenerative diseases during the early stages has be...
Alzheimer disease (AD) represents the most common neurodegenerative disease worldwide, accounting fo...
PublishedJournal ArticleResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA marker...
OBJECTIVE: Peripheral protein biomarkers of Alzheimer's disease (AD) may help identify novel treatme...
Mainly obtained from familial Alzheimer’s disease patients’ data, we know that some features of the ...
Background and Objectives: The search for accurate biomarkers in Alzheimer Disease (AD), on of the m...
A major barrier to the effective conduct of clinical trials of new drug candidates against Alzheimer...
© 2019 - IOS Press and the authors. All rights reserved. Background: Differential diagnosis of peopl...
Alzheimer’s disease (AD) is the most common cause of dementia, affecting the central nervous system ...
PublishedJournal ArticleMulticenter StudyResearch Support, Non-U.S. Gov'tBACKGROUND: The study aimed...
Previous mass spectrometry analysis of cerebrospinal fluid (CSF) has allowed the identification of a...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
Article examines molecular markers of neuropsychological functioning among elders with and without A...
AbstractBackgroundThe current project sought to examine molecular markers of neuropsychological func...
Prior work on the link between blood-based biomarkers and cognitive status has largely been based on...
The ability to detect the presence of many neurodegenerative diseases during the early stages has be...
Alzheimer disease (AD) represents the most common neurodegenerative disease worldwide, accounting fo...
PublishedJournal ArticleResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA marker...
OBJECTIVE: Peripheral protein biomarkers of Alzheimer's disease (AD) may help identify novel treatme...
Mainly obtained from familial Alzheimer’s disease patients’ data, we know that some features of the ...
Background and Objectives: The search for accurate biomarkers in Alzheimer Disease (AD), on of the m...
A major barrier to the effective conduct of clinical trials of new drug candidates against Alzheimer...
© 2019 - IOS Press and the authors. All rights reserved. Background: Differential diagnosis of peopl...
Alzheimer’s disease (AD) is the most common cause of dementia, affecting the central nervous system ...
PublishedJournal ArticleMulticenter StudyResearch Support, Non-U.S. Gov'tBACKGROUND: The study aimed...
Previous mass spectrometry analysis of cerebrospinal fluid (CSF) has allowed the identification of a...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...